Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F95S8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,809
Award facts
- Contract value 100% obligated
- $15,809.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $15,809.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections. This non-competitive, non-set-aside order was issued on December 22, 2025, with completion scheduled for December 23, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis and other allergic and inflammatory conditions, making this a critical pharmaceutical supply for military healthcare beneficiaries.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor to DLA's global medical supply chain, AmerisourceBergen leverages this comprehensive contract vehicle to supply a wide range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The firm fixed-price structure and rapid one-day completion timeline reflect DLA's urgent medical procurement needs within its established vendor relationship.
Quick answers
Who was awarded contract SPE2DR26F95S8?
SPE2DR26F95S8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F95S8 worth?
The government has obligated $15,809 on SPE2DR26F95S8.
Is contract SPE2DR26F95S8 an order under another contract?
Yes. SPE2DR26F95S8 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F95S8 competed?
The extent of competition for SPE2DR26F95S8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award